![]() Eyenovia Eyenovia is a late-stage biopharmaceutical company with three lead programs in glaucoma, mydriasis and dry eye with a transformative ophthalmic delivery platform. | ||||
Founding Date | Founding Date 2014 | Founding Date 2016 | Founding Date 2010 | Founding Date 2014 |
Type | Type Public | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations New York, US HQ | Locations Baltimore, US HQ | Locations Fremont, US HQ | Locations Boston, US HQ |
Employees | Employees 22100% increase | Employees 2717% increase | Employees 2262% increase | Employees 802% decrease |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 1.2m (over 6 years ago) | Latest funding round $ 35m (about 11 years ago) | Latest funding round $ 36m (almost 8 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 3.6m | Total funding raised $ 53m | Total funding raised $ 95m |

CoapTech is a medical device company aiming to improve medical care delivery for patients.
View company
Ceterix Orthopaedics develops novel surgical tools for arthroscopic procedures.
View companyEmulate is a biotechnology company that specializes in organ-on-chips technology.
View company